Israel hospital covid-19 infection Israel

COVID-19 Scan for Feb 12, 2021

Reading now: 423
www.cidrap.umn.edu

Study shows strong 1-dose immune response with Pfizer vaccineA single dose of the Pfizer-BioNTech COVID-19 vaccine was immunogenic in 92% of recipients, with no difference in immunogenic response between men and women but a decreasing response among older recipients, researchers from Israel's Bar-Ilan University reported yesterday in Eurosurveillance.The research also showed that, among those with previous evidence of infection with SARS-CoV-2, the virus that causes COVID-19, the immune response to a single dose was significantly stronger.In the study, 514 Israeli healthcare workers received the vaccine and had their antibody levels measured before vaccination and 21 days after the first dose.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA